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!"-tubulin H3K27me3 histone peptide pull-downs were performed with nuclear extracts of LF2 ESC prior or after 5 days of RA-induced differentiation. Biotinylated histone peptides (H3 peptide, residues 18 to 37, unmodified or trimethylated at K27) were conjugated to Streptavidin beads, and peptide pulldowns followed by Cbx7 IB were conducted as described in the and control cells were generated as described under experimental procedures and probed for levels of endogenous and exogenous Cbx7 protein, using anti-GFP or anti-Cbx7
antibodies. These cells were used to identify Cbx7-containing PRC1 complexes in ESCs as described in Fig 2B. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Plasmids
The miR-181a/b and miR-125b seed mutants were generated by mutagenesis changing 5 bp (miR-181a) or 6 bp (miR181b and miR-125b) in the seed region.
psiCHECK2-Cbx7-3'UTR was prepared by subcloning Cbx7 3'UTR from the full length mouse Cbx7 cDNA (Gil et al., 2004 ) by PCR after the 3' end of the Renilla luciferase gene.
The human CBX7-3'UTR reporter was cloned likewise using a fosmid construct as template. psiCHECK2-Cbx7-3'UTR mutant constructs were created by mutagenesis deleting the 6-bp miRNA recognition region. Lentiviral pLKO-based shRNA targeting Cbx7
(pLKO-shCbx7.1 and pLKO-shCbx7.2) were obtained from Thermo Scientific (clone IDs were TRCN0000096729 and TRCN0000019145 respectively). To generate Cbx7-EGFP, The Cbx7 heterozygous mutant 'KO first' allele contains a standard !-geo trapping cassette targeted by replacement mutagenesis into the intron 1-2 of Cbx7. 46C (Aubert et al., 2003) and Oct4-GIP reporter (Ying et al., 2002) ESCs were maintained in KO-DMEM supplemented with 10% FBS, L-Glutamine 2mM, Non Essential Aminoacids (NEAA) 100
"M, ß-Mercaptoethanol 0.1 mM and LIF 1000 U/ml. P19 mouse teratocarcinoma cells were maintained in #MEM media supplemented with 10% FBS. Mouse ESC lines B05 (Cbx7 +/-) and F05 (Cbx7 +/-), CCE, E14, ZHBTc4, LF2, and PGK12.1 were plated on 0.1% gelatincoated plates or on a feeder layer of irradiated MEFs, and maintained in DMEM supplemented with 15% FBS, 1 mM L-glutamine, 0.1 mM nonessential amino acids, 100 µg ml$1 penicillin, 100 µg ml$1 streptomycin, 1 mM sodium pyruvate, 0.1 mM 2-mercaptoethanol and recombinant LIF (Millipore). Retinoic acid induced differentiation was performed by plating ESC on 0.1% gelatin-coated plates in ESC media lacking LIF with Retinoic acid (10-7 M). Embryoid body (EB) differentiation was performed by plating ESCs into non-adherent conditions in ES media lacking LIF for up to 20 days. ZHBTc4 were differentiated through the addition of doxycycline as previously described (Niwa et al., 2000) . For neural differentiation, ESC were cultured as described (Ying et al., 2003) . P19 mouse teratocarcinoma cells were differentiated using 1 "M of All-trans-Retinoic acid (Sigma). HEK293T and IMR90 cells were obtained from the ATCC and maintained in Dulbecco's modified Eagle's medium (Invitrogen) with 10% fetal bovine serum (PAA) and 1% antibiotic-antimycotic solution (Invitrogen).
Mass Spectrometry. SILAC-labelled total or nuclear extracts from ESC, differentiated ESC, Cbx7-EGFP ESC and MEF were generated as described (Graumann et al., 2008) and used for peptide pull-down, Ring1b IP or GFP IP. Quantitative mass spectrometry experiments were performed essentially as described (Vermeulen et al., 2010) . The 3D mass spectrum presented in Fig 1A was generated using MaxQuant .
Peptide pulldown assays. Peptide pulldown assays were performed as described (Wysocka, 2006) with small modifications. Biotinylated histone peptides corresponding to aa 18-35, 18-37 or 18-38 of histone H3, unmodified (U) or trimethylated on K27 (me3) were used. Peptides were conjugated to avidin agarose beads (Pierce, 20219) or Neutravidin resin for 4 hrs at RT. Peptide pulldown assays were performed using a solubilised chromatin fraction, which was incubated for 3 hours at 4 C. To prepare the extracts, nuclei
were isolated by incubation in ice-cold sucrose buffer (0.32M sucrose, 10mM Tris pH 8.0, 3mM CaCl 2 2mM MgOAc, 0.1mM EDTA and 1mM DTT) supplemented with proteinase inhibitors and either 0.5% or 1% TritonX-100. The quality of the nuclear preps was confirmed visually. 0.2-1x10 8 nuclei were used per assay. The nuclei were incubated in lysis buffer (20Mm HEPES pH 7.9, 25% glycerol, 420 mM KCl, 1.5 mM MgCl 2 , 0.2mM EDTA, 1mM DTT) and subjected to 3 cycles of freezing and thawing, followed by centrifugation. The supernatant was collected as the nuclear fraction, while chromatin pellets were solubilised by MNaseI digestion. The nuclear and chromatin fractions were pooled together and used for the chromatin capture assay. For each assay, 3 independent extractions were performed and the extracts were pooled together. Extracts were adjusted to 150 mM KCl and pre-cleared. Pre-cleared extracts were then incubated overnight with Cterminally biotinylated histone peptides coupled to Neutravidin resin or avidin agarose beads. Beads were then washed 4 or 5 times with ice-cold wash buffer (20mM HEPES pH 7.9, 20% glycerol, 150mM KCl, 0.2mM EDTA, 0.2% TritonX-100). Bound proteins were eluted by boiling in Laemmli buffer and loaded on SDS-PAGE gel and detected by massspectrometry or immunoblotting. Streptavidin blotting served as a loading control for peptides in the immunoblot experiments GFP immunoprecipitation. GFP-trap beads (Chromotek) were used to precipitate GFP from ESC expressing GFP or Cbx7-EGFP. Approximately 4 mg of total cell lysate were used per pulldown in a buffer containing 150mM NaCl, 1% NP40, 50mM Tris-HCl pH 7.6 and protease inhibitors. After incubating samples at 4°C for 2 hours, beads were washed repeatedly and eluted with 2x Laemmli buffer at 95°C for 10 min.
Ring1b immunoprecipitation.
Approximately, 2.5x10 8 cells were used per IP. Nuclear extracts prepared as described for the peptide pulldown assays were precleared with 100 µl of protein G-agarose for 1 h at 4°C, prior to overnight incubation at 4°C with Ring1B antibody (using 5 µg antibody/mg extract). In the morning, Protein G-agarose beads were added and incubated for 3 additional hours at 4°C. After incubation, beads were washed several times and eluted with 2x Laemmli buffer at 95°C for 10 min. Quantitative RT-PCR analysis. Total RNA was extracted using miRCURY RNA isolation kit (Exiqon) or RNeasy kit (Qiagen). cDNAs were generated using SuperScript II reverse transcriptase (Invitrogen 
Chromatin immunoprecipitation (ChIP).
For ChIP analysis proteins bound to DNA were cross-linked using 1.42% formaldehyde for 10 min at room temperature followed by addition of glycine (0.125 M final concentration) for 5 min at room temperature. After washing with ice-cold PBS, cells were collected by centrifugation, washed once with ChIP buffer (150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, NP-40 (0.5% vol/vol), Triton X-100 (1.0%
vol/vol) and Complete protease inhibitors, Roche), and lysed in the same buffer for 30 min on ice. Following sonication protein-DNA complexes were immunoprecipitated overnight at 4°C with rotation using primary antibodies Immunoprecipitated chromatin was incubated with Protein G beads for another 5 h at 4ºC and then washed and eluted by incubation with elution buffer (2% SDS, 100 mM NaHCO3, 10 mM DTT). Crosslinking was reversed by incubation at 65˚C overnight. DNA was purified by phenol-chloroform extraction, followed by ethanol precipitation. Real-time PCR reactions using SYBR green (Roche) were performed in triplicate using primers for the correspondent genomic regions. Fold enrichment over 1% input was calculated using the 2DeltaCt method. The data presented in Bioinformatic analysis. Raw ChIP-seq data pluripotency factors binding (Nanog, Sox2
and Oct4) (Marson et al., 2008) were downloaded from GEO (GSE11724), with data in SRA format transformed into Fastq format using the SRA toolkit 2.0.1. Sequence data was aligned to MM9 genome using Bowtie version 0.12.7, coverage for aligned reads calculated using Bedtools version 2.12.2 and the resulting bigWig files visualized in the UCSC genome browser. 
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